These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 33076392)

  • 41. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
    Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas.
    Cabanillas R; Astudillo A; Valle M; de la Rosa J; Álvarez R; Durán NS; Cadiñanos J
    Head Neck; 2013 Mar; 35(3):E80-4. PubMed ID: 22083977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver.
    Weihrauch M; Markwarth A; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
    Hum Pathol; 2002 Sep; 33(9):884-92. PubMed ID: 12378512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CDKN2A germline splicing mutation affecting both p16(ink4) and p14(arf) RNA processing in a melanoma/neurofibroma kindred.
    Petronzelli F; Sollima D; Coppola G; Martini-Neri ME; Neri G; Genuardi M
    Genes Chromosomes Cancer; 2001 Aug; 31(4):398-401. PubMed ID: 11433531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.
    Bardeesy N; Aguirre AJ; Chu GC; Cheng KH; Lopez LV; Hezel AF; Feng B; Brennan C; Weissleder R; Mahmood U; Hanahan D; Redston MS; Chin L; Depinho RA
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5947-52. PubMed ID: 16585505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P; Zaravinos A; Zioga M; Spandidos DA
    Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
    Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G
    EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A.
    McKenzie HA; Fung C; Becker TM; Irvine M; Mann GJ; Kefford RF; Rizos H
    Hum Mutat; 2010 Jun; 31(6):692-701. PubMed ID: 20340136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inverse association of p16 INK4a and p14 ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer.
    Verdoodt B; Sommerer F; Palisaar RJ; Noldus J; Vogt M; Nambiar S; Tannapfel A; Mirmohammadsadegh A; Neid M
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):295-301. PubMed ID: 21912429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ratio of expression of p16INK4a to p14ARF correlates with the progression of non-small cell lung cancer.
    Moriyama S; Nakashima Y; Yano M; Kaji M; Yamakawa Y; Toyama T; Yamashita H; Iwase H; Sasaki H; Saito Y; Kiriyama M; Kato J; Fujii Y
    Jpn J Cancer Res; 2002 Jul; 93(7):783-8. PubMed ID: 12149144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific Deletion of p16
    Ishida K; Tomita H; Kanayama T; Noguchi K; Niwa A; Kawaguchi M; Miyai M; Matsuo M; Imaizumi Y; Kato K; Hatano Y; Hirata A; Okada H; Shibata T; Hara A
    Am J Pathol; 2020 Jun; 190(6):1332-1342. PubMed ID: 32194051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF.
    Pasmant E; Laurendeau I; Héron D; Vidaud M; Vidaud D; Bièche I
    Cancer Res; 2007 Apr; 67(8):3963-9. PubMed ID: 17440112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.
    Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A
    Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients.
    Soufir N; Daya-Grosjean L; de La Salmonière P ; Moles JP; Dubertret L; Sarasin A; Basset-Seguin N
    J Natl Cancer Inst; 2000 Nov; 92(22):1841-7. PubMed ID: 11078762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations of the p16(INK4) locus in human malignant mesothelial tumors.
    Hirao T; Bueno R; Chen CJ; Gordon GJ; Heilig E; Kelsey KT
    Carcinogenesis; 2002 Jul; 23(7):1127-30. PubMed ID: 12117769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of the head and neck.
    Weber A; Wittekind C; Tannapfel A
    Pathol Res Pract; 2003; 199(6):391-7. PubMed ID: 12924439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma.
    Vieth M; Schneider-Stock R; Röhrich K; May A; Ell C; Markwarth A; Roessner A; Stolte M; Tannapfel A
    Virchows Arch; 2004 Aug; 445(2):135-41. PubMed ID: 15185075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.
    Altomare DA; Menges CW; Xu J; Pei J; Zhang L; Tadevosyan A; Neumann-Domer E; Liu Z; Carbone M; Chudoba I; Klein-Szanto AJ; Testa JR
    PLoS One; 2011 Apr; 6(4):e18828. PubMed ID: 21526190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
    Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
    Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma.
    Lesueur F; de Lichy M; Barrois M; Durand G; Bombled J; Avril MF; Chompret A; Boitier F; Lenoir GM; ; Bressac-de Paillerets B; Baccard M; Bachollet B; Berthet P; Bonadona V; Bonnetblanc JM; Caron O; Chevrant-Breton J; Cuny JF; Dalle S; Delaunay M; Demange L; De Quatrebarbes J; Doré JF; Frénay M; Fricker JP; Gauthier-Villars M; Gesta P; Giraud S; Gorry P; Grange F; Green A; Huiart L; Janin N; Joly P; Kérob D; Lasset C; Leroux D; Limacher JM; Longy M; Mansard S; Marrou K; Martin-Denavit T; Mateus C; Maubec E; Olivier-Faivre L; Orlandini V; Pujol P; Sassolas B; Stoppa-Lyonnet D; Thomas L; Vabres P; Venat L; Wierzbicka E; Zattara H
    Br J Cancer; 2008 Jul; 99(2):364-70. PubMed ID: 18612309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.